Epidemiology and behaviour

News and research on people’s sexual and drug-using behaviour and the impact this has on the spread of HIV in the community.

Other topics in this section

Epidemiology and behaviour: latest news

Epidemiology and behaviour resources

Epidemiology and behaviour features

Epidemiology and behaviour news from aidsmap

More news

Epidemiology and behaviour news selected from other sources

  • South Africa: SA 'Falling Short' On HIV Prevention Goals

    South Africa's struggle to meet its HIV treatment coverage goals, combined with strong evidence of reduced condom use, is key to the slow progress in achieving reduced HIV incidence, according to a new study released by the University of Cape Town (UCT) yesterday

    16 June 2019 | AllAfrica

  • Africa: New HIV Map Offers Most Detailed Look Yet At The Epidemic

    A study published Wednesday presents what these researchers describe as the most detailed map ever produced of HIV prevalence across sub-Saharan Africa. The first-of-its-kind new map may help increase the precision of the HIV/AIDS response as some data-savvy researchers narrow their focus on the continent's worst-affected areas — to the size of a small town.

    16 May 2019 | NPR

  • UK couples having less frequent sex than 10 years ago

    "Young Brits are having less sex than a decade ago because they're too busy watching Netflix," reports the Sun. Researchers used survey data from almost 35,000 people aged 16 to 44 in the UK. The surveys were done in 1991, 2001 and 2012.

    10 May 2019 | NHS Behind the Headlines

  • Cocaine injecting and homelessness linked to Glasgow HIV outbreak

    Rising HIV infections among people who inject drugs in Glasgow reveals changes in injecting behaviours, with cocaine injecting becoming more common – a practice with greater HIV risks

    07 May 2019 | AVERT

  • HIV Incidence and Risk Behaviours of People Who Inject Drugs in Bangkok, 1995–2012

    HIV incidence in people who inject drugs in Bangkok declined from 5.7 per 100 person-years during the cohort study, to 2.7 per 100 person-years in the vaccine trial, to 0.7 per 100 person-years among PrEP study placebo recipients. Incidence peaked at 12.1 per 100 person-years in 1996 and declined to <1.0% during 2005–2012. Several factors likely contributed to the decline, including decreases in the frequency of injecting and sharing, improved access to HIV testing and antiretroviral therapy, and the use of PrEP. Expanding access to effective HIV prevention tools can hasten control of the HIV epidemic among PWID.

    01 April 2019 | The Lancet

  • HIV hitting Latino men in California at an alarming rate

    “One in four Latino men in the Valley in 2020 who have sex with men will test positive for HIV in their lifetimes,” said Oscar Lopez, vice president of policy, advocacy, education and communication for the Valley AIDS Council. Lopez just returned from the 2019 NHPC Hispanic/Latin MSM and Trans Latina Meeting with the CDC in Atlanta. Latino leaders met to discuss a plan of action in response to staggering numbers released in October by the CDC.

    01 April 2019 | The Monitor

  • Molecular data helps identify HIV networks

    Using molecular data to supplement information gained through public health interviews — chiefly, the names of sexual or needle-sharing partners — can help identify HIV transmission networks and prevent new infections in states with low HIV morbidity, researchers reported in a recent MMWR.

    05 March 2019 | Healio

  • Ireland: The new HIV crisis needs a better response

    HIV is a public heath issue, but a spike in diagnoses in Ireland seems to be going unchecked. New figures published last week show there were 531 new cases of HIV infections diagnosed in 2018, an increase from 492 in 2017. There is now a new diagnosis of HIV in Ireland every 17 hours; Ireland’s rate of new diagnoses stood at 10.2 per 100,000 people in 2017, while the European average is 6.2 per 100,000.

    04 March 2019 | Irish Times

  • Decline in U.S. HIV Infection Rate Stalled From 2013 to 2016

    According to the Centers for Disease Control and Prevention’s (CDC) new HIV surveillance report, the estimated annual HIV transmission rate in the United States declined modestly between 2010 and 2013 and then stagnated through 2016. The CDC has contradicted its own previous reports by characterizing this recent trend as a plateau that followed a “dramatic decline.” HIV incidence declined during the 2010 to 2016 period among white men who have sex with men (MSM) and among heterosexuals. However, troubling increases in the transmission rate among Latino MSM, and Black MSM between 25 and 34 years old, have offset such promising trends.

    28 February 2019 | POZ

  • Young black gay and bisexual men in US 16 times more likely to acquire HIV

    This is despite reporting the lowest number of sexual partners, new study says

    07 December 2018 | Gay Star News
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.